Clinical Trial Update: Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a chemoradiation regimen of docetaxel, oxaliplatin, capecitabine, and fluorouracil with radiation for locally advanced esophageal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Esophageal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-10